120 related articles for article (PubMed ID: 2442320)
21. Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
Innes A; May PC; Pavlů J; Bain BJ
Am J Hematol; 2012 Apr; 87(4):412. PubMed ID: 21953481
[No Abstract] [Full Text] [Related]
22. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
23. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
24. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
[TBL] [Abstract][Full Text] [Related]
25. The angiographic response of osteosarcoma following pre-operative chemotherapy.
Kumpan W; Lechner G; Wittich GR; Salzer-Kuntschik M; Delling G; Kotz R; Hajek P; Sekera J
Skeletal Radiol; 1986; 15(2):96-102. PubMed ID: 2421415
[TBL] [Abstract][Full Text] [Related]
26. Late cardiotoxicity after treatment for a malignant bone tumor.
Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA
Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333
[TBL] [Abstract][Full Text] [Related]
27. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.
Provisor AJ; Ettinger LJ; Nachman JB; Krailo MD; Makley JT; Yunis EJ; Huvos AG; Betcher DL; Baum ES; Kisker CT; Miser JS
J Clin Oncol; 1997 Jan; 15(1):76-84. PubMed ID: 8996127
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms.
Rosen G
Recent Results Cancer Res; 1986; 103():148-57. PubMed ID: 2426747
[No Abstract] [Full Text] [Related]
29. Secondary cerebral astrocytoma 3 years after diagnosis of primary osteogenic sarcoma: a case report.
Lanning M; Heikkinen E; Lanning P
Pediatr Hematol Oncol; 1987; 4(2):153-5. PubMed ID: 2484649
[TBL] [Abstract][Full Text] [Related]
30. Acute myeloid leukaemia with t(9;11)(p22;q23) in a patient treated for adult T cell leukaemia.
Nakamura H; Ishizaki T; Itoyama T; Soda H; Yoshida Y; Yamada Y; Kuriyama K; Sadamori N; Tomonaga M
Br J Haematol; 1994 Jan; 86(1):222-4. PubMed ID: 8011538
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.
Meyers PA; Heller G; Healey J; Huvos A; Lane J; Marcove R; Applewhite A; Vlamis V; Rosen G
J Clin Oncol; 1992 Jan; 10(1):5-15. PubMed ID: 1370176
[TBL] [Abstract][Full Text] [Related]
32. [Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].
Boussen H; Mezzi F; Gamoudi A; Daldoul O; Ben Hamida H; Mezlini A; Khalfallah S; Karray S; Ben Romdhane K; Ben Ghachem M; Ben Abdallah M; Douik M; Saadi A; Ben Ayed F; Ben Hassine H
Bull Cancer; 2000 Feb; 87(2):183-8. PubMed ID: 10705289
[TBL] [Abstract][Full Text] [Related]
33. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.
Meyers PA; Gorlick R; Heller G; Casper E; Lane J; Huvos AG; Healey JH
J Clin Oncol; 1998 Jul; 16(7):2452-8. PubMed ID: 9667263
[TBL] [Abstract][Full Text] [Related]
34. Disposition of high-dose methotrexate in an obese cancer patient.
Fleming RA; Eldridge RM; Johnson CE; Stewart CF
Cancer; 1991 Sep; 68(6):1247-50. PubMed ID: 1714790
[TBL] [Abstract][Full Text] [Related]
35. Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma.
Pappo A; Schneider NR; Sanders JM; Buchanan GR
Cancer; 1991 Sep; 68(6):1373-5. PubMed ID: 1714791
[TBL] [Abstract][Full Text] [Related]
36. [Current aspects of the treatment of osteogenic sarcoma].
Glukhovskaia IIu; Tolstopiatov BA; Butenko AK; Konovalenko VF
Klin Khir; 1995; (5):32-3. PubMed ID: 8646629
[No Abstract] [Full Text] [Related]
37. RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma.
Thomson B; Hawkins D; Felgenhauer J; Radich J
Bone Marrow Transplant; 1999 Sep; 24(5):527-33. PubMed ID: 10482938
[TBL] [Abstract][Full Text] [Related]
38. What has adjuvant chemotherapy of osteosarcoma achieved? Discussion paper.
Souhami RL
J R Soc Med; 1983 Nov; 76(11):943-6. PubMed ID: 6195337
[No Abstract] [Full Text] [Related]
39. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
40. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology].
Bielack S; Knop J; Delling G; Winkler K
Nuklearmedizin; 1988 Dec; 27(6):237-41. PubMed ID: 2464164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
